<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03133429</url>
  </required_header>
  <id_info>
    <org_study_id>MER</org_study_id>
    <nct_id>NCT03133429</nct_id>
  </id_info>
  <brief_title>Clinical Study to Evaluate the Safety and Effectiveness of MER® Stents in Carotid Revascularisation.</brief_title>
  <acronym>MER</acronym>
  <official_title>Badanie Kliniczne oceniające bezpieczeństwo i skuteczność Stosowania stentów Szyjnych MER® w Rewaskularyzacji tętnic Szyjnych.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balton Sp.zo.o.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>KCRI</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Balton Sp.zo.o.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to confirm, whether the MER® stent can be used, without limitations,
      for the endovascular carotid stenosis treatment in daily clinical practice. Eligible patients
      will undergo the procedure of the common or internal carotid artery stenting using MER® with
      proximal or distal neuroprotection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MER® stent will be implanted in eligible patients with common and internal carotid stenosis
      after an informed consent.

      Potential benefit of the MER® stent implantation will be evaluated based on angiography and
      duplex Doppler ultrasound examination.

      Follow ups are scheduled at 30 days, 6 and 12 months after index procedure. Except for
      clinical follow up patients will undergo carotid vessels ultrasound examination after 6 and
      12 months. In case of an emergency visit, caused by the Serious Adverse Event, Patient will
      undergo: neurological and cardiac evaluation as well as carotid vessels USG examination and
      extended CT or MRI scans.

      In general, all procedures in the study will follow the local standard of care. The type of
      devices used during the angioplasty (including the MER® stents) will not differ from the
      devices used in the usual clinical practice in the hospital. DAPT and other medical therapy
      will be consistent with the rules of the Polish and European Society of Cardiology.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stroke within 30 days after the procedure</measure>
    <time_frame>30 days</time_frame>
    <description>Stroke within 30 days after the procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MAE</measure>
    <time_frame>30 days</time_frame>
    <description>compound Major Adverse Events (death, stroke, heart attack) within 30 days after the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MAE</measure>
    <time_frame>365 days</time_frame>
    <description>compound Major Adverse Events (death, stroke, heart attack) within 365 days after the procedure. Restenosis (%DS ≥50%) within 365 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularization within 365 days</measure>
    <time_frame>365 days</time_frame>
    <description>Target vessel revascularization within 365 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure success</measure>
    <time_frame>365 days</time_frame>
    <description>Procedure success (with residual stenosis ≤30%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SADE</measure>
    <time_frame>365 days</time_frame>
    <description>Serious Adverse Device Effect</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Carotid Artery Stenosis</condition>
  <arm_group>
    <arm_group_label>Patients with MER stent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients eligible for Carotid Artery Stenting</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MER</intervention_name>
    <description>carotid artery stenting</description>
    <arm_group_label>Patients with MER stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  De novo lesion located in the internal carotid artery or common carotid artery

               -  DS ≥50% (nonsymptomatic patients) and ≤99% based on QCA

               -  DS ≥75% (symptomatic patients) and ≤99% based on QCA

          -  Target lesion available for 20-60mm lenght and 4-10mm diameter scaffold

          -  Patient eligible for CAS

          -  Age ≥ 18

          -  Life expentancy ≥ 12 months

          -  The patient's written informed consent has been obtained prior to the procedure.

        Exclusion Criteria:

          -  Lack of neurological CAS qualification

          -  The patient has experienced an acute myocardial infarction within 72 hours of the
             procedure

          -  The patient has known paroxysmal, persistent or permanent atrial fibrillation or
             flutter

          -  The patient has known gastrointestinal bleeding

          -  Pregnancy

          -  DAPT contraindications

          -  Surgery planned within 1 month after the procedure

          -  A platelet count &lt;100,000/mm³ or &gt;600,000/mm³

          -  The patient has known nickel, titanium or contrast allergy

          -  The target vessel is totally occluded

          -  The patient has stent(s) in the target lesion

          -  Statin therapy contraindications

          -  The target lesion has massive calcifications

          -  Hyperthyroidism

          -  Post-radiotherapy side effects

          -  No pulse in femoral artery

          -  Chronic kidney disease (creatinine level &gt;2,0 mg/dl or eGFR&lt;30 mL/min/1.73 m2 or
             dialysotherapy)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Piotr Odrowąż-Pieniążek, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oddział Kliniczny Chorób Serca i Naczyń Krakowski Szpital Specjalistyczny im. Jana Pawła II ul. Prądnicka 80 31-202 Kraków</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paweł Buszman, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>I Oddział Kardiologiczno-Angiologiczny American Heart of Poland S.A. ul. Sanatoryjna 1 43-450 Ustroń</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Beata Brożek-Wojdyła</last_name>
    <email>beata.brozek@kcri.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elżbieta Sojka</last_name>
    <email>elzbieta.sojka@balton.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Małopolskie Centrum Sercowo-Naczyniowe PAKS American Heart of Poland S.A. Oddział Chirurgi naczyniowej</name>
      <address>
        <city>Chrzanow</city>
        <zip>32-500</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Przemysław Nowakowski, Dr n med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny nr 7 Śląskiego Uniwersytetu Medycznego w Katowicach, Górnośląskie Centrum Medyczne im. Prof. Leszka Gieca Oddział Chirurgii Ogólnej, Naczyń, Angiologii i Flebologii</name>
      <address>
        <city>Katowice</city>
        <zip>40-635</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krzysztof Ziaja, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oddział Kliniczny Chorób Serca i Naczyń Krakowski Szpital Specjalistyczny im. Jana Pawła II</name>
      <address>
        <city>Krakow</city>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piotr Odrowąż-Pieniążek, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>I Oddział Kardiologiczno-Angiologiczny American Heart of Poland S.A.</name>
      <address>
        <city>Ustron</city>
        <zip>43-450</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Centrum Interwencyjnego Leczenia Udaru i Chorób Naczyniowych Mózgu Instytut Psychiatrii i Neurologii</name>
      <address>
        <city>Warszawa</city>
        <zip>02-957</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Kobayashi, Dr hab. med</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <reference>
    <citation>Maciejewski D, Pieniążek P, Tekieli L, Paluszek P, Dzierwa K, Trystuła M, Wójcik-Pędziwiatr M, Podolec P. Transradial approach for carotid artery stenting in a patient with severe peripheral arterial disease. Postepy Kardiol Interwencyjnej. 2014;10(1):47-9. doi: 10.5114/pwki.2014.41469. Epub 2014 Mar 23.</citation>
    <PMID>24799929</PMID>
  </reference>
  <reference>
    <citation>Dzierwa K, Pieniazek P, Tekieli L, Musialek P, Przewlocki T, Kablak-Ziembicka A, Kosobucka-Peszat R, Machnik R, Trystula M, Podolec P. Carotid artery stenting according to the &quot;tailored CAS&quot; algorithm performed in the very elderly patients: the thirty day outcome. Catheter Cardiovasc Interv. 2013 Nov 1;82(5):681-8. doi: 10.1002/ccd.25025. Epub 2013 Jul 3.</citation>
    <PMID>23825008</PMID>
  </reference>
  <reference>
    <citation>Pieniążek P, Tekieli L, Musiałek P, Kabłak Ziembicka A, Przewłocki T, Motyl R, Dzierwa K, Paluszek P, Hlawaty M, Żmudka K, Podolec P. Carotid artery stenting according to the tailored-CAS algorithm is associated with a low complication rate at 30 days: data from the TARGET-CAS study. Kardiol Pol. 2012;70(4):378-86.</citation>
    <PMID>22528713</PMID>
  </reference>
  <reference>
    <citation>Musialek P, Pieniazek P, Tracz W, Tekieli L, Przewlocki T, Kablak-Ziembicka A, Motyl R, Moczulski Z, Stepniewski J, Trystula M, Zajdel W, Roslawiecka A, Zmudka K, Podolec P. Safety of embolic protection device-assisted and unprotected intravascular ultrasound in evaluating carotid artery atherosclerotic lesions. Med Sci Monit. 2012 Feb;18(2):MT7-18.</citation>
    <PMID>22293887</PMID>
  </reference>
  <reference>
    <citation>Dzierwa K, Pieniazek P, Musialek P, Piatek J, Tekieli L, Podolec P, Drwiła R, Hlawaty M, Trystuła M, Motyl R, Sadowski J. Treatment strategies in severe symptomatic carotid and coronary artery disease. Med Sci Monit. 2011 Aug;17(8):RA191-197. Review.</citation>
    <PMID>21804476</PMID>
  </reference>
  <reference>
    <citation>Pieniazek P. [A new era for the stenting of the carotid arteries in the light of the CREST study]. Kardiol Pol. 2010 Sep;68(9):1086-7. Polish.</citation>
    <PMID>20859914</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2017</study_first_submitted>
  <study_first_submitted_qc>April 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2017</study_first_posted>
  <last_update_submitted>December 12, 2017</last_update_submitted>
  <last_update_submitted_qc>December 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>carotid artery</keyword>
  <keyword>stroke</keyword>
  <keyword>stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

